https://www.selleckchem.com/pr....oducts/recilisib.htm
Automatic segmentation of brain tumors has the potential to enable volumetric measures and high-throughput analysis in the clinical setting. Reaching this potential seems almost achieved, considering the steady increase in segmentation accuracy. However, despite segmentation accuracy, the current methods still do not meet the robustness levels required for patient-centered clinical use. In this regard, uncertainty estimates are a promising direction to improve the robustness of automated segmentation systems. Different uncertainty est
Like
Comment
Share
